AU2001262952A1 - Fullerene-based drugs targeted to bone - Google Patents

Fullerene-based drugs targeted to bone

Info

Publication number
AU2001262952A1
AU2001262952A1 AU2001262952A AU6295201A AU2001262952A1 AU 2001262952 A1 AU2001262952 A1 AU 2001262952A1 AU 2001262952 A AU2001262952 A AU 2001262952A AU 6295201 A AU6295201 A AU 6295201A AU 2001262952 A1 AU2001262952 A1 AU 2001262952A1
Authority
AU
Australia
Prior art keywords
fullerene
bone
based drugs
drugs targeted
targeted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001262952A
Inventor
Kelly A. Gonzales
Kenneth Pritzker
Uri Sagman
Lon J. Wilson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
William Marsh Rice University
Original Assignee
William Marsh Rice University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by William Marsh Rice University filed Critical William Marsh Rice University
Publication of AU2001262952A1 publication Critical patent/AU2001262952A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nanotechnology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001262952A 2000-04-27 2001-04-27 Fullerene-based drugs targeted to bone Abandoned AU2001262952A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19997000P 2000-04-27 2000-04-27
US60199970 2000-04-27
PCT/US2001/013445 WO2001080898A1 (en) 2000-04-27 2001-04-27 Fullerene-based drugs targeted to bone

Publications (1)

Publication Number Publication Date
AU2001262952A1 true AU2001262952A1 (en) 2001-11-07

Family

ID=22739776

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001262952A Abandoned AU2001262952A1 (en) 2000-04-27 2001-04-27 Fullerene-based drugs targeted to bone

Country Status (2)

Country Link
AU (1) AU2001262952A1 (en)
WO (1) WO2001080898A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6436386B1 (en) * 2000-11-14 2002-08-20 Shearwater Corporation Hydroxyapatite-targeting poly (ethylene glycol) and related polymers
US7829074B2 (en) 2001-10-18 2010-11-09 Nektar Therapeutics Hydroxypatite-targeting poly(ethylene glycol) and related polymers
EP1867337B1 (en) * 2005-03-23 2014-10-01 St. Marianna University School of Medicine Medicinal composition comprising a fullerene for treating/preventing motor organ disease involving cartilage degeneration
CA2659600A1 (en) * 2006-08-02 2008-02-07 Board Of Regents Of The University Of Nebraska Drug carriers, their synthesis, and methods of use thereof
EP2087886B1 (en) * 2006-10-20 2014-12-10 St. Marianna University School of Medicine Therapeutic agent for rheumatoid arthritis

Also Published As

Publication number Publication date
WO2001080898A1 (en) 2001-11-01

Similar Documents

Publication Publication Date Title
AU2001269529A1 (en) Medicine comprising dicyanopyridine derivative
AU2002217979A1 (en) Medicine feeder
AU5367101A (en) Surgical targeting system
AU2001253451A1 (en) Patient compliance monitor
AU3747001A (en) Arrangement for patient monitor
AUPQ867900A0 (en) Medical injector system
AU2001288462A1 (en) Medical instrument
AU2001232360A1 (en) Medical instrument
AU2001269508A1 (en) Drugs or cosmetics
AU2001256020A1 (en) Biological sounds monitor
AU2001264671A1 (en) Latency monitor
AU4439701A (en) Patient support
AU2001259702A1 (en) Tissue regrafting
AU6715600A (en) Pharmaceutical formulations
AU2001256201A1 (en) Device for administering implants
AU2002221099A1 (en) Combination drugs
AU2001243515A1 (en) Combination drug therapy
AUPQ761100A0 (en) Lipophilic medicament
AU2001264631A1 (en) Medical instrument
AU2002227925A1 (en) Human beta-defensin-3
AU4977300A (en) Pharmaceutical formulations
AU3533601A (en) Pacifier
AU2001270129A1 (en) Human phosphodiesterases
AU1385801A (en) Pharmaceutical formulations
AU2001262952A1 (en) Fullerene-based drugs targeted to bone